MENU

Sangamo Therapeutics Aktie (NASDAQ:SGMO)

The Company deals in the research, development and commercialization of DNA-binding proteins for the therapeutic regulation and modification of disease-related genes.

{{ formattedPrice }} {{ change }} (2,92 %)

Quotes delayed. Last trade: 18-01-2019, 10:00:00pm CET

SGMO vs. S&P 500
Eröffnung {{ openPrice }} Schlusskurs {{ closePrice }}
Tages-Hoch {{ high }} Tages-Tief {{ low }}
Geld {{ bid }} Brief {{ ask }}
Volumen 1090880    

Related Articles